Cutaneous T cell lymphoma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
{{Cutaneous T cell lymphoma}} | {{Cutaneous T cell lymphoma}} | ||
{{CMG}}; {{AE}} {{AS}} | {{CMG}}; {{AE}} {{AS}} | ||
{{SK}} | |||
{{SK}} Mycosis fungoides; Sezary syndrome; Sezary's disease | |||
==[[Cutaneous T cell lymphoma overview|Overview]]== | ==[[Cutaneous T cell lymphoma overview|Overview]]== | ||
Revision as of 14:41, 20 January 2016
For patient information, click here
|
Cutaneous T cell lymphoma Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Synonyms and keywords: Mycosis fungoides; Sezary syndrome; Sezary's disease
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cutaneous T cell lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | Biopsy | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Cost-Effectiveness of Therapy | Future or Investigational Therapies